why is tirzepatide no longer available FDA says years-long shortage resolved, will give limited leeway to compounders What to Expect After Starting

FDA-approved uses Wegovy is FDA-approved for chronic weight management in patients with obesity (body mass index 30 kg/m or greater) and overweight (body mass index 27 kg/m or greater) with at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, high cholesterol levels, and heart disease, when used as an adjunct to a healthy lifestyle, reduced-calorie diet, and exercise

3.Marso SP, et al

MEDICAL DISCLAIMER: This product information is for educational purposes only

Can I join the lawsuit if I live outside the United States

Tirzepatide (Mounjaro) Tirzepatide is noteworthy for its ability to target both GLP-1 and GIP receptors, a mechanism that can be particularly helpful for PCOS patients struggling with obesity and insulin resistance